| E-Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Health and Fitness > Medicine > Cholesterol Guidelines: Appropriate Target Levels For You |
|
E-Articles - Cholesterol Guidelines: Appropriate Target Levels For You
Cholesterol guidelines provide general target levels for doctors and can help patients to gain a better understanding about desired ranges. Your doctor will be aware of current guidelines for cholesterol but wil According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product l also take into account other risk factors. There are differing target levels for patients and your doctor will set one for you after evaluating your overall cardiovascular risk profile. “But . . . I am too you ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ng." Not necessarily. If you have a number of risk factors or have diabetes, you may have high cholesterol. If you have familial hypercholesterolemia, you will have high levels of low-density lipoprotein (LDL), w lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. ich leads to premature atherosclerosis of the coronary arteries. Getting older can also make a difference. Your cholesterol levels can change as you age. Men over 40 and women over 50 should be tested. Choleste here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe rol guidelines can help you to see where you should be. Here is what a sample chart for Canada looks like. Low Risk LDL: treat when greater than 5.0 mmol/L Total Cholesterol-HDL Cholesterol Ratio: treat d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro when greater than 6.0 Moderate Risk LDL: treat when greater than 3.5 mmol/L Total Cholesterol-HDL Cholesterol Ratio: treat when greater than 5.0 High Risk LDL: (target treatment) less than 2.0 mmol/L Total ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc Cholesterol-HDL Cholesterol Ratio: (target treatment) less than 4.0 Guidelines for cholesterol are based on the latest research involving cholesterol and cardiovascular disease. When your doctor consults these r easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi ecommendations, they help him to determine your risk and to set your target cholesterol level. Cholesterol guidelines include other recommendations: A lower intake of saturated fat A higher level of HDL Cl nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ser monitoring or testing of triglycerides U.S. guidelines for cholesterol suggest that a HDL level of less than 40 mg/dL is a risk factor for heart disease. New recommendations suggest lowering LDL. Other reco and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ mmendations: adults should also have a lipoprotein analysis every 5 years. Triglycerides, total cholesterol, LDL, and HDL are measured. Cholesterol guidelines set the new target for cholesterol at less than 200 m ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi per day. Total Cholesterol: below 200 mg/dL LDL Cholesterol: less than 130 mg/dL HDL Cholesterol: more than 35 mg/dL Guidelines for cholesterol also suggest that adults consume approximately 35% of calories ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a from total fat and no more than 7% from saturated fat. You may be advised to change what you eat and how you prepare it so that your fat consumption adheres more closely to current recommendations. Trans-fats an dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod d saturated fats are implicated in heart disease and reducing these can help. What You Need To Know Saturated fats in the diet force the body to make too much cholesterol Animal foods are loaded with cholest cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin rol and saturated fats
Fast foods are high in fats
If you eat lots of meat and fast foods, you will most likely have high cholesterol Did You Know? Heart disease risk is reduced by up to 40% when cholestero tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen l levels are lowered. People are increasingly turning to natural supplements containing important compounds that can help to combat high cholesterol levels. Plants contain catechins, phytochemicals, polyphenols, t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel sterols, and flavonoids, which render significant beneficial effects. Policosanol is a natural substance derived from sugar cane. Numerous trials have demonstrated that it can safely and effectively lower choles ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust terol. If you are seeking to bring levels into ranges suggested by cholesterol guidelines, policosanol is an e y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products ffective substance that reduces LDL and raises HDL. Policosanol may be combined with other compounds: beta-sitosterol (for hypercholesterolemia); green tea (with powerful catechins); lecithin oil (for high chole . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de terol); oryzanol rice bran oil (containing cholesterol-lowering phytosterols); and vitamin E (for treating atherosclerosis). Guidelines for cholesterol may change; however, adopting healthful eating habits and s elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip upporting cardiovascular health with proven substances can help, if you are trying to correct imbalances. It is important to discuss current cholesterol guidelines and potential treatments with your practitioner tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Effective Presentations - Dress For Success Employer Identification Numbers and Sole Proprietors DISH Network HDTV Programming - HD Programs and Service Guide
|